Does Long-Term Entecavir Treatment Really Reduce Hepatocellular Carcinoma Incidence in Patients With Hepatitis B Virus Infection? Reply

被引：1
|
作者：
Hosaka, Tetsuya [1 ]
Suzuki, Fumitaka [1 ]
Kumada, Hiromitsu [1 ]
机构：
[1] Toranomon Gen Hosp, Dept Hepatol, Tokyo, Japan
来源：
HEPATOLOGY | 2014年 / 59卷 / 05期
关键词：
LAMIVUDINE;
D O I：
10.1002/hep.26774
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：2053 / 2054
页数：2
相关论文
共 50 条
  • [21] Similar risk of hepatocellular carcinoma during long-term entecavir or tenofovir therapy in Caucasian patients with chronic hepatitis B
    Wen, Zhili
    Feng, Yuliang
    Yan, Xiaohua
    JOURNAL OF HEPATOLOGY, 2021, 74 (01) : 245 - 246
  • [22] Similar risk of hepatocellular carcinoma during long-term entecavir or tenofovir therapy in Caucasian patients with chronic hepatitis B
    Papatheodoridis, George, V
    Dalekos, George N.
    Idilman, Ramazan
    Sypsa, Vana
    Van Boemmel, Florian
    Buti, Maria
    Calleja, Jose Luis
    Goulis, John
    Manolakopoulos, Spilios
    Loglio, Alessandro
    Papatheodoridi, Margarita
    Gatselis, Nikolaos
    Veelken, Rhea
    Lopez-Gomez, Marta
    Hansen, Bettina E.
    Savvidou, Savvoula
    Kourikou, Anastasia
    Vlachogiannakos, John
    Galanis, Kostas
    Yurdaydin, Cihan
    Esteban, Rafael
    Janssen, Harry L. A.
    Berg, Thomas
    Lampertico, Pietro
    JOURNAL OF HEPATOLOGY, 2020, 73 (05) : 1037 - 1045
  • [23] Reactivation of Occult Hepatitis B Virus Infection During Long-Term Entecavir Antiviral Therapy
    Yuan, Chunyan
    Peng, Jing
    Xia, Renxiang
    He, Jian
    Qiu, Tianji
    Yao, Yunqing
    FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [24] Long-term follow-up of cumulative incidence of hepatocellular carcinoma in hepatitis B virus patients without antiviral therapy
    Xiao-Yan Jiang
    Bing Huang
    Dan-Ping Huang
    Chun-Shan Wei
    Wei-Chao Zhong
    De-Ti Peng
    Fu-Rong Huang
    Guang-Dong Tong
    World Journal of Gastroenterology, 2021, 27 (11) : 1101 - 1116
  • [25] Long-term follow-up of cumulative incidence of hepatocellular carcinoma in hepatitis B virus patients without antiviral therapy
    Jiang, Xiao-Yan
    Huang, Bing
    Huang, Dan-Ping
    Wei, Chun-Shan
    Zhong, Wei-Chao
    Peng, De-Ti
    Huang, Fu-Rong
    Tong, Guang-Dong
    WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (11) : 1101 - 1116
  • [26] Does hepatitis B virus therapy reduce the risk of hepatocellular carcinoma?
    Ridruejo, Ezequiel
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (03) : 439 - 451
  • [27] Impact of Long-Term Tenofovir Disoproxil Fumarate on Incidence of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
    Kim, W. Ray
    Loomba, Rohit
    Berg, Thomas
    Schall, Raul E. Aguilar
    Yee, Leland J.
    Dinh, Phillip V.
    Flaherty, John F.
    Martins, Eduardo B.
    Therneau, Terry M.
    Jacobson, Ira
    Fung, Scott
    Gurel, Selim
    Buti, Maria
    Marcellin, Patrick
    CANCER, 2015, 121 (20) : 3631 - 3638
  • [28] Does antiplatelet therapy really reduce the risk of hepatocellular carcinoma in hepatitis B patients with antiviral drugs?
    Lo, Gin-Ho
    HEPATOLOGY, 2018, 67 (04) : 1642 - 1643
  • [29] LONG-TERM EFFICACY AND IMPACT ON HEPATOCELLULAR CARCINOMA DEVELOPMENT OF NUCLEOSIDE ANALOGUE TREATMENT WITH LAMIVUDINE AND ENTECAVIR FOR CHRONIC HEPATITIS B AND CIRRHOSIS
    Kobashi, H.
    Miyake, Y.
    Ikeda, F.
    Yasunaka, T.
    Nishino, K.
    Moriya, A.
    Kubota, J. -I.
    Nakamura, S.
    Takaki, A.
    Nouso, K.
    Yamada, G.
    Yamamoto, K.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S291 - S292
  • [30] Suppressive effects of entecavir on hepatitis B virus and hepatocellular carcinoma
    Jin, Young-Joo
    Shim, Ju Hyun
    Lee, Han Chu
    Yoo, Dong-Jun
    Kim, Kang Mo
    Lim, Young-Suk
    Suh, Dong Jin
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 (09) : 1380 - 1388
12345